Trevi Therapeutics, Inc. (TRVI): Weighted Average Diluted Shares

Annual figures by period end, from SEC filings.

134.75M
Year ended 2025-12-31
2021-12-31: 22.84M2022-12-31: 64.54M2023-12-31: 99.03M2024-12-31: 101.97M2025-12-31: 134.75M134.75M
2021-12-31 Weighted Average Diluted Shares (shares) 2025-12-31
Period endedWeighted Average Diluted SharesChange YoYSource filing
2025-12-31134.75M+32.1%2026-03-17, From 2025-01-01
2024-12-31101.97M+3.0%2026-03-17, From 2024-01-01
2023-12-3199.03Mn/c2025-03-18, From 2023-01-01
2022-12-3164.54M+182.6%2024-03-20, From 2022-01-01
2021-12-3122.84Mn/a2023-03-16, From 2021-01-01